| Product Code: ETC8287508 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Prophylactic Vaccines Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Mexico Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Mexico Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Mexico Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Mexico Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Mexico Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Mexico Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Mexico Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government focus on immunization programs |
4.2.2 Rising awareness about the importance of vaccination |
4.2.3 Growing incidence of infectious diseases in Mexico |
4.3 Market Restraints |
4.3.1 High vaccine costs leading to affordability issues |
4.3.2 Limited access to healthcare facilities in remote areas |
5 Mexico Prophylactic Vaccines Market Trends |
6 Mexico Prophylactic Vaccines Market, By Types |
6.1 Mexico Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Mexico Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 Mexico Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 Mexico Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 Mexico Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 Mexico Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 Mexico Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 Mexico Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Mexico Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 Mexico Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 Mexico Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 Mexico Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 Mexico Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 Mexico Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 Mexico Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 Mexico Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 Mexico Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Mexico Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 Mexico Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 Mexico Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 Mexico Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 Mexico Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 Mexico Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Mexico Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Mexico Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 Mexico Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Mexico Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Mexico Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Mexico Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Mexico Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 Mexico Prophylactic Vaccines Market Export to Major Countries |
7.2 Mexico Prophylactic Vaccines Market Imports from Major Countries |
8 Mexico Prophylactic Vaccines Market Key Performance Indicators |
8.1 Number of individuals covered under government immunization programs |
8.2 Percentage increase in vaccination rates over time |
8.3 Number of new vaccines introduced in the market |
9 Mexico Prophylactic Vaccines Market - Opportunity Assessment |
9.1 Mexico Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Mexico Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Mexico Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Mexico Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Mexico Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Mexico Prophylactic Vaccines Market - Competitive Landscape |
10.1 Mexico Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Mexico Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here